BCFS00834-Precigen-Gulley-CervicalCancer [Landing Page]

Apply Now Cervical CancerInvestigational Treatment Study Researchers at Precigen are conducting a research study in individuals with recurrent or metastatic cervical cancer to evaluate an investigational drug. Apply Now Fast Facts Recurrent or Metastatic Cervical Cancer Ages 18+ Had Unsuccessful Treatment with Pembrolizumab Conducted Nationwide Study Background Researchers at Precigen want to evaluate an investigational […]